Transmitting medicine
The transmitting medicine is an actively developing cross-disciplinary knowledge domain. Its task – to integrate elements of clinical medicine and biotechnology approaches into developments of new therapeutic and diagnostic means. Development of the innovation methods of diagnostics, creation of new medical devices, artificial organs, fabric engineering and also gene and cellular therapies is among its most priority purposes. In many respects from that, how fast the last developments in this directions of science will be implemented into clinical practice, the competitiveness of domestic medicine and pharmaceutics depends.
One of the key directions of transmitting medicine is work with clinical trials of medicines in public and preclinical tests for animals. This important link through which there pass the created medicines and medical technologies that from "prototype" to turn into widely put treatment method into practice. And the quicker more effectively clinical and preclinical trials will also be conducted, the quicker patients will be able to get access to new technologies of treatment. Therefore a considerable part of reports of a plenary session is devoted to this direction.
According to Olga Loginovskaya, the director of quality and corporate development of Flex Databases company and the participant of a scientific session, one of key problems of the organization of clinical trials the essential deviation from test plan is. "Recently the Cutting Edge Information company published data, – Olga Loginovskaya explains the point of view, – according to which modern clinical trials seldom come to the end just in time. On the I phase average deviation from the plan makes about 42%, on II – 31%, on III – 30%. 60–70% of all time are the share of clinical trials, more than 90% of the budget also are the share of them. It is possible to reduce time for an output of new medicine for the market due to upgrade of management of clinical trials and the modern systems of electronic collecting and data processing".